Navigation Links
Gladstone's Lennart Mucke receives Lifetime Achievement Award from the Alzheimer's Association
Date:7/15/2012

SAN FRANCISCO, CAJuly 15, 2012Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.

Dr. Mucke has spent most of his career uncovering the molecular and cellular mechanisms that cause memory loss and behavioral abnormalities in Alzheimer's disease and related conditions. For example, he and his colleagues showed that amyloid-beta, apoE4 and tauthree proteins closely linked to the development of Alzheimer'scan impair cognitive functions by impeding the communication among brain cells and disrupting the fine balance between excitation and inhibition that is required for the proper function of neural networks. Most importantly, Dr. Mucke has identified new therapeutic targets and experimental strategies to block these disease-causing processes and to make the brain more resistant to disease.

"Dr. Mucke is making tremendous strides in the advancement of Alzheimer's research," said William Thies, PhD, who is the Alzheimer's Association's chief medical and scientific officer. "The passion and dedication shown by Dr. Mucke and others in this field will hopefully bring us closer to a much-needed cure for the Alzheimer's epidemic."

Alzheimer's disease affects an estimated 5.4 million people in the United States. If current trends continue, this number may triple by 2050. And yet no approved drugs exist to prevent, halt or reverse this debilitating diseasewhich robs people of memory, other critical brain functions and, ultimately, their life. Dr. Mucke expects that an effective Alzheimer's solution will include multiple therapies to address the numerous proteins implicated in the diseaseincluding amyloid-beta, apoE4 and tauin much the same way that hypertension, cancer and severe infections often require treatment with combinations of different remedies.

"I am deeply honored to receive this Lifetime Achievement Award," said Dr. Mucke, who is also a professor of neurology and the Joseph B. Martin Distinguished Professor of Neuroscience at the University of California, San Francisco, with which Gladstone is affiliated. "We have made enormous strides towards understanding the complexities of Alzheimer's. There is considerable work yet to be donebut I believe we are closer than ever to preventing, treating and ultimately overcoming this devastating disease."

Before joining Gladstone in 1996, Dr. Mucke was an associate professor at The Scripps Research Institute. He has received numerous honors and awards, including the Zenith Award from the Alzheimer's Association, the MetLife Foundation Award for Medical Research and the Potamkin Prize from the American Academy of Neurology. Dr. Mucke is a member of the American Neurological Association, the Association of American Physicians and the Dana Alliance for Brain Initiatives. He serves on the National Advisory Council on Aging for the National Institutes of Health, a Medical and Scientific Advisory Council of the Alzheimer's Association and the Senate of the German Center for Neurodegenerative Diseases.


'/>"/>
Contact: Diane Schrick
diane.schrick@gladstone.ucsf.edu
415-734-2538
Gladstone Institutes
Source:Eurekalert

Related medicine news :

1. Loyola Cancer Center receives Outstanding Achievement Award
2. MU receives national award for using mind-body approach to improve health
3. Neuropsychologist receives University of Houstons highest faculty honor
4. Boston researcher, surgical oncologist receives national award
5. LA BioMed receives Grand Challenges Explorations grant
6. Lawson researcher receives 1 of first-ever Pfizer Psychiatry Research Awards
7. Dr. Arthur Slutsky, vice-president of research at St. Michaels, receives lifetime award
8. UC San Diego Superfund Research Program receives $15 million grant renewal
9. Markey receives $6.25 million to study deadly blood and bone marrow disease
10. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
11. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional Budget Office (CBO) ... House on May 4, would result in 23 million Americans losing their health insurance ... 2010 Patient Protection and Affordable Care Act (ACA). , “It is clear from ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public ... American. Viewers can reconnect with America as it explores some of the best places ... looked for an inventive new place for a family vacation, and have discovered hiking. ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
(Date:5/24/2017)... ... May 24, 2017 , ... Last ... Mary Ellen, hospital employees, and town officials to celebrate the grand opening of ... developed by Rendina as part of its ongoing relationship with RWJBarnabas Health, New ...
(Date:5/24/2017)... ... 24, 2017 , ... NucleusHealth ™, advancing clinical practice ... Food and Drug Administration (FDA) 510(k) clearance for its Nucleus.io ... for medical image management. At the core is patented streaming technology that provides ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... , May 4, 2017  Fortuna Fix Inc. (" Fortuna ... be the first to eliminate the need for embryonic and ... to treat neurodegenerative diseases. Fortuna announced ... Professor Michael Fehlings , MD, PhD; Father Kevin ... MD, MPH; and Professor James Giordano , PhD. ...
(Date:5/4/2017)... 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it is teaming up with ... Limited to lower diabetes healthcare costs in ... which is available throughout all provinces and territories in ... eligible for additional savings when shopping for Dario supplies ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
Breaking Medicine Technology: